Articles

Experts and leaders from the local and global generic and biosimilar medicines industry, Government and…

From the desk of Henry Leng – One of the limitations in the development of…

Just over ten years ago I was part of a collaborative research project that investigated…

By courtesy of and issued by: BONITAS Medical Aid It is common knowledge that healthcare…

Immunogenicity- From the desk of Henry Leng – In a previous blog I have stated…

The International Generic and Biosimilar medicines Association (IGBA) announced today that it has established a CEO Advisory Committee composed of…

Biosimilars are cost-effective alternatives to innovator biologics used for the treatment of chronic debilitating and…

IGBA, the International Generic and Biosimilar Medicines Association (IGBA), representing global manufacturers of generic and…

We all know that the registration of biosimilars in any jurisdiction with a competent regulatory…

The interruption in international supply chains, which ensued in the wake of the COVID-19 pandemic…

Biosimilar – Recently, I had the opportunity to visit a biotechnology company to review their…

The newly established IGBA CEO Advisory Committee, a forum for generic and biosimilar medicines industry leaders…